deflazacort has been researched along with citric acid, anhydrous in 1 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (citric acid, anhydrous) | Trials (citric acid, anhydrous) | Recent Studies (post-2010) (citric acid, anhydrous) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 11,894 | 783 | 4,366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzori, L; Bandino, F; Carta, F; Chuchueva, N; Fanos, V; Lussu, M; Noto, A; Peppi, M; Puxeddu, R | 1 |
1 other study(ies) available for deflazacort and citric acid, anhydrous
| Article | Year |
|---|---|
Metabolomic analysis of urine with Nuclear Magnetic Resonance spectroscopy in patients with idiopathic sudden sensorineural hearing loss: A preliminary study.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Alanine; Anticoagulants; Audiometry, Pure-Tone; Case-Control Studies; Child; Citric Acid; Cohort Studies; Creatinine; Enoxaparin; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Male; Metabolomics; Methylamines; Middle Aged; Pregnenediones; Prognosis; Prospective Studies; Proton Magnetic Resonance Spectroscopy; Urine; Young Adult | 2017 |